Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure.
Guedeney P, Farjat-Pasos JI, Asslo G, Roule V, Beygui F, Hermida A, Gabrion P, Leborgne L, Houde C, Huang F, Lattuca B, Leclercq F, Mesnier J, Abtan J, Rouanet S, Hammoudi N, Collet JP, Zeitouni M, Silvain J, Montalescot G, Rodés-Cabau J; AIR-FORCE Task Force.
Guedeney P, et al. Among authors: gabrion p.
Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):601-607. doi: 10.1093/ehjcvp/pvad023.
Eur Heart J Cardiovasc Pharmacother. 2023.
PMID: 36963773